Back
Prelude Therapeutics Stock Predictions
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
21
PRLD
Prelude Therapeutics
Last Price:
1.15
Seasonality Move:
21.44%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.Prelude Therapeutics Stock Forecast
-
Is Prelude Therapeutics Stock Undervalued?
The current Prelude Therapeutics [PRLD] share price is $1.20. The Score for PRLD is 21, which is 58% below its historic median score of 50, and infers higher risk than normal. - PRLD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Prelude Therapeutics Stock Go Up Next Year?
Data Unavailable
Prelude Therapeutics Stock Rating
Data Unavailable
Prelude Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
preludetx.com
52-Week Data
52-Week High:
6.80
52-Week Low:
1.10
Prediction Charts
Market Cap:
65.77M
Price in USD:
1.20
Volume:
282.86K
Beta:
1.55
Technical Analysis
SMA50:
2.43
SMA100:
3.71
SMA200:
3.88
52-Wk Change:
-60.3%
Stock Predictions
-
Is Prelude Therapeutics stock public?
Yes, Prelude Therapeutics is a publicly traded company. -
What is the Prelude Therapeutics stock quote today?
The Prelude Therapeutics stock price is 1.20 USD today. -
How to buy Prelude Therapeutics stock online?
You can buy Prelude Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-23 | 1.73 | 1.64 | 1.76 | 1.58 |
| Oct-24 | 1.67 | 1.55 | 1.67 | 1.55 |
| Oct-25 | 1.54 | 1.52 | 1.58 | 1.50 |
| Oct-28 | 1.51 | 1.50 | 1.58 | 1.48 |
| Oct-29 | 1.50 | 1.42 | 1.53 | 1.39 |
| Oct-30 | 1.40 | 1.32 | 1.42 | 1.32 |
| Oct-31 | 1.31 | 1.21 | 1.33 | 1.10 |
| Nov-1 | 1.25 | 1.24 | 1.34 | 1.24 |
| Nov-4 | 1.25 | 1.20 | 1.29 | 1.20 |
| Nov-5 | 1.21 | 1.29 | 1.32 | 1.18 |
| Nov-6 | 1.21 | 1.32 | 1.34 | 1.21 |
| Nov-7 | 1.32 | 1.27 | 1.36 | 1.26 |
| Nov-8 | 1.25 | 1.19 | 1.29 | 1.14 |
| Nov-11 | 1.20 | 1.20 | 1.24 | 1.19 |
Prelude Therapeutics Earnings
Data Unavailable
Prelude Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.31 per share.
* Prelude Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.